Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about INFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neuroinflammation is a key driver of neurodegenerative disease progression. It involves activation of microglia and astrocytes, release of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), complement cascade activation, and blood-brain barrier disruption. While acute inflammation is neuroprotective, chronic neuroinflammation exacerbates neuronal damage. Key pathways include NF-kB, JAK-STAT, NLRP3 inflammasome, and TLR signaling.
No AI portrait yet
| Gene Symbol | INFLAMMATION |
| Astrocyte activation marker | Rises in response to CNS injury |
| Disease progression marker | Correlates with clinical decline |
| Treatment response marker | Sensitive to therapeutic intervention |
| Minocycline | Microglia/astrocyte modulator |
| NP036 | mGluR5 negative allosteric modulator |
| AZD3241 | Myeloperoxidase inhibitor |
| Anti-GFAP antibodies | Neutralize toxic GFAP fragments |
| IL-6 receptor antibodies | Block astrocyte-derived inflammation |
| Ibuprofen | NSAID with astrocyte effects |
| Metformin | Metabolic modulator |
| Fingolimod | S1P receptor modulator |
| Associated Diseases | Aging, Als, Alzheimer, ALZHEIMER'S DISEASE |
| Known Drugs/Compounds | BERBERINE, BPMC, C-Phycocyanin, CURCUMIN, DIMETHYL FUMARATE, Flavonoids |
| Interactions | 6-OHDA, ABCA1, ABCA7, ABCB1, ABCD1, ABCD2 |
| KG Connections | 6338 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Signaling["Signaling"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| MICROGLIA["MICROGLIA"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| CANCER["CANCER"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| NRF2["NRF2"]
INFLAMMATION["INFLAMMATION"] -->|"activates"| Inflammation["Inflammation"]
INFLAMMATION["INFLAMMATION"] -->|"regulates"| Autophagy["Autophagy"]
INFLAMMATION["INFLAMMATION"] -->|"regulates"| Mtor["Mtor"]
IL6["IL6"] -->|"activates"| INFLAMMATION["INFLAMMATION"]
AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| INFLAMMATION["INFLAMMATION"]
P53["P53"] -->|"regulates"| INFLAMMATION["INFLAMMATION"]
CYTOKINES_2["CYTOKINES"] -.->|"inhibits"| INFLAMMATION["INFLAMMATION"]
end
subgraph Pathology["Pathology"]
INFLAMMATION["INFLAMMATION"] -->|"associated with"| AGING["AGING"]
CYTOKINES["CYTOKINES"] -->|"associated with"| INFLAMMATION["INFLAMMATION"]
end
subgraph Therapeutic["Therapeutic"]
INFLAMMATION["INFLAMMATION"] -->|"therapeutic target"| Als["Als"]
INFLAMMATION["INFLAMMATION"] -->|"therapeutic target"| Autoimmune["Autoimmune"]
CYTOKINES_1["CYTOKINES"] -->|"therapeutic target"| INFLAMMATION["INFLAMMATION"]
end
style INFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style MICROGLIA fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CANCER fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NRF2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AGING fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autoimmune fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Mtor fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style IL6 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style P53 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | associated_with | disease | 1.00 |
| Epigenetic | therapeutic_target | pathway | 1.00 |
| Inflammasome | activates | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Oxidative Stress | regulates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Blood-Brain Barrier | activates | pathway | 1.00 |
| Nf-Κb | regulates | pathway | 1.00 |
| Angiogenesis | therapeutic_target | pathway | 1.00 |
| Mtor | regulates | pathway | 1.00 |
| Mapk | inhibits | pathway | 1.00 |
| Toll-Like Receptor | activates | pathway | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Mitochondrial Function | therapeutic_target | pathway | 1.00 |
| MICROGLIA | activates | cell_type | 1.00 |
| Apoptosis | regulates | pathway | 1.00 |
| Ferroptosis | therapeutic_target | pathway | 1.00 |
| Autophagy | therapeutic_target | pathway | 1.00 |
| Complement | regulates | pathway | 1.00 |
| Apoptosis | inhibits | pathway | 1.00 |
| Complement | therapeutic_target | pathway | 1.00 |
| Autoimmune | associated_with | disease | 1.00 |
| Autophagy | inhibits | pathway | 1.00 |
| Adaptive Immunity | activates | pathway | 1.00 |
| Mtor | therapeutic_target | pathway | 1.00 |
| Senescence | associated_with | disease | 1.00 |
| NRF2 | activates | gene | 1.00 |
| Immune Response | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | therapeutic_target | pathway | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| Complement | activates | pathway | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Immune Response | regulates | pathway | 1.00 |
| Als | associated_with | disease | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Nf-Κb | inhibits | pathway | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Innate Immunity | activates | pathway | 1.00 |
| Innate Immunity | regulates | pathway | 1.00 |
| Epigenetic | regulates | pathway | 1.00 |
| Epigenetic | activates | pathway | 1.00 |
| CANCER | activates | disease | 1.00 |
| Tgf-Β | activates | pathway | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| Blood-Brain Barrier | therapeutic_target | pathway | 1.00 |
| Oxidative Stress | inhibits | pathway | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Glycolysis | regulates | pathway | 1.00 |
| Mitophagy | regulates | pathway | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AUTOPHAGY | activates | gene | 1.00 |
| CGAS-STING | activates | gene | 1.00 |
| NEUROTOXICITY | activates | gene | 1.00 |
| AUTOPHAGY | interacts_with | gene | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| PYROPTOSIS | activates | gene | 1.00 |
| P62 | inhibits | gene | 1.00 |
| APP | activates | gene | 1.00 |
| RAGE | inhibits | gene | 1.00 |
| ALS | activates | gene | 1.00 |
| MIRNAS | regulates | gene | 1.00 |
| AMYOTROPHIC LATERAL SCLEROSIS | therapeutic_target | gene | 1.00 |
| MYD88 | activates | gene | 1.00 |
| BECN1 | activates | gene | 1.00 |
| P62 | activates | gene | 1.00 |
| JAK2 | inhibits | gene | 1.00 |
| GENES | expressed_in | gene | 1.00 |
| NRF2 | activates | gene | 1.00 |
| MICRORNAS | therapeutic_target | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| C-JUN | activates | gene | 1.00 |
| CD8 | activates | gene | 1.00 |
| DNA | therapeutic_target | gene | 1.00 |
| MTDNA | activates | gene | 1.00 |
| BCL-2 | activates | gene | 1.00 |
| SQSTM1 | activates | gene | 1.00 |
| OPTN | activates | gene | 1.00 |
| PTEN | activates | gene | 1.00 |
| IL6 | activates | protein | 1.00 |
| PINK1 | activates | gene | 1.00 |
| DNA | regulates | gene | 1.00 |
| MITOCHONDRIAL DNA | activates | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| MTOR | regulates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| DNA | activates | gene | 1.00 |
| MTOR | therapeutic_target | gene | 1.00 |
| APOE | inhibits | gene | 1.00 |
| APOE | therapeutic_target | gene | 1.00 |
| STAT3 | activates | gene | 1.00 |
| SIRT1 | activates | gene | 1.00 |
| GFAP | biomarker_for | gene | 1.00 |
| IL6 | inhibits | gene | 1.00 |
| ATG5 | inhibits | gene | 1.00 |
| TLR4 | inhibits | gene | 1.00 |
| BDNF | activates | gene | 1.00 |
| OVERVIEW | therapeutic_target | gene | 1.00 |
| TREM2 | activates | gene | 1.00 |
| CGAS | activates | gene | 1.00 |
| VIRAL INFECTIONS | activates | gene | 1.00 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.682
neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630
neurodegeneration | 2026-04-16 | 14 hypotheses Top: 0.806
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-10 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| PGC-1α knockout analysis of PV+ interneuron maturation | validation | neurodevelopmental disorders | 0.850 | 0.00 | knockout mice | proposed | N/A |
| PV+ interneuron subtype diversification analysis | exploratory | neurodevelopmental disorders | 0.750 | 0.00 | mouse cortical PV+ interneuron | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] | Krasemann S, Madore C, Cialic R, Baufeld | Immunity | 2017 | 1 |
| Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage d [PMID:41509917] | Choi C, Lee J, Park G, Namgoong S, Lee Y | iScience | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438] | Hegdekar N, Sarkar C, Bustos S, Ritzel R | Autophagy | 2023 | 0 |
| Inflammasome assembly in neurodegenerative diseases. [PMID:37633753] | Singh J, Habean ML, Panicker N | Trends in neurosciences | 2023 | 0 |
| NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938] | Li S, Sun Y, Song M, Song Y, Fang Y, Zha | JCI insight | 2021 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407] | Gordon R, Albornoz EA, Christie DC, Lang | Science translational medicine | 2018 | 0 |
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to ch [PMID:16862116] | Unknown | Nature | 2006 | 0 |
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia l [PMID:16862115] | Unknown | Nature | 2006 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.67 · 2026-04-28
closed · Rounds: 4 · Score: 0.60 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 1.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.76 · 2026-04-23
closed · Rounds: 4 · Score: 0.78 · 2026-04-22
closed · Rounds: 4 · Score: 0.67 · 2026-04-22
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
Hypotheses and analyses mentioning INFLAMMATION in their description or question text
Score: 0.714 · alzheimers · 2026-04-04
## Mechanistic Overview Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Phagocytosis from Inflammation starts f
Score: 0.710 · neurodegeneration · 2026-04-22
## Mechanistic Overview Microglial Disease-Associated States: TREM2-Independent Pathways Driving Neuroinflammation start
Score: 0.703 · neurodegeneration · 2026-04-16
**Molecular Mechanism and Rationale** The pathogenesis of Parkinson's disease (PD) involves complex interactions betwee
Score: 0.680 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The molecular mechanism underlying AQP4-mediated neuroinflammation centers on the
Score: 0.670 · neurodegeneration · 2026-04-25
This hypothesis reconciles conflicting C1q phenotypes by placing receiver-cell state downstream of a common upstream C1q
Score: 0.665 · unknown disease · 2026-04-26
Reactive astrocytes release GFAP-positive extracellular vesicles (Astrocyte-EVs) into circulation with end-feet retracti
Score: 0.650 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio
Score: 0.643 · neuroinflammation · 2026-04-21
## **Molecular Mechanism and Rationale** The epigenetic silencing of the AIF1 (Allograft Inflammatory Factor 1) gene lo
Score: 0.626 · unknown disease · 2026-04-16
## Mechanistic Overview Peripheral-to-Central Inflammation Circuit Breaker starts from the claim that modulating IL1B wi
Score: 0.610 · neuroscience · 2026-04-22
**Molecular Mechanism and Rationale** The apolipoprotein E4 (APOE4) isoform, present in approximately 25% of the popula
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Score: 0.587 · alzheimers · 2026-04-04
# Cardiovascular-Neuroinflammation Crosstalk Interruption: Targeting Shared Inflammatory Mediators in Neurodegeneratio
Score: 0.580 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflammation starts fr
Score: 0.580 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The proposed mechanism centers on a complex inflammatory cascade initiated by APO